Report updated May 19, 2026
Cuspart: Blood Sugar
For individuals managing diabetes or glucose levels who require a private, offline-capable tool for health tracking and clinical reporting.
Cuspart: Blood Sugar is an established medical app that is free with in-app purchases. With a 5.0/5 rating from 1 reviews, it shows polarized user reception.
What is Cuspart: Blood Sugar?
Cuspart is a medical tracking app for diabetes management that uses a local-first, one-time payment model on iOS and Android.
Users hire Cuspart to maintain clinical health records without the privacy risks or recurring costs associated with cloud-synced medical trackers.
Current Momentum
v1.33 · 1mo ago
Maintenance- Launched Android version in April 2026.
- Maintains one-time purchase model.
Active Nemesis
Shotsy GLP-1 Tracker
By Shotsy
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Log glucose, insulin, and vitals without an active internet connection
Generate and share health history reports for physician review
Store all health data locally on the device rather than on external servers
How much does it cost?
- Free tier with core tracking features
- Pro tier via one-time payment for full offline functionality
Freemium model utilizing a one-time purchase to unlock offline capabilities, avoiding recurring subscription fatigue.
Who Built It?
Mustafa Tolga DALBUDAK
Providing specialized utility and productivity tools for professionals and students. Focused on offline-first functionality for everyday tasks.
Portfolio
13
Apps
What other apps does Mustafa Tolga DALBUDAK make?
Explore the full Mustafa Tolga DALBUDAK report
Portfolio breakdown, audience, momentum, and every app published by Mustafa Tolga DALBUDAK.
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Cuspart: Blood Sugar?
Where is it available?
Localized markets (19)
How's The Medical Market?
Market outlook for this category
Available very soon
Which niche is Cuspart: Blood Sugar in?
to track blood glucose and health metrics
Explore the full Diabetes Management Trackers niche
Every app in this space — 46 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Nemeses(1)
NimbleRx dominates the medical space by integrating prescription fulfillment directly into the user's health management workflow, creating a high-barrier ecosystem that captures users beyond simple data tracking.
Contenders(4)
It competes for the same 'chronic condition management' user base, specifically targeting those who use diet and food tracking to control metabolic markers.
This app targets the specific niche of GLP-1 medication users, competing for the same demographic of patients managing metabolic health and glucose levels.
Differentiators
- Prioritizes local-first data storage, appealing to privacy-conscious users wary of cloud-based health data syncing
- Integrates Siri voice commands to reduce friction in logging medication and glucose levels on-the-go
As a hospital-backed application, it competes for the trust of patients requiring verified medical record access and professional-grade health monitoring.
This app competes by offering an AI-driven conversational interface for health data, directly challenging the target's goal of turning complex data into actionable insights.
Same space(3)
This app competes by offering high-end ecosystem integration, specifically targeting users who want their glucose data to flow seamlessly across all Apple devices.
Differentiators
- Supports Live Activities and CarPlay, offering superior glanceable data access for users on the move
- Deep calendar integration allows users to correlate glucose spikes with specific scheduled daily events
This app provides a traditional, feature-rich logging experience for diabetes management, serving as a direct alternative for users who prefer manual data entry.
It is a direct peer in the glucose tracking space, specifically targeting users who prioritize wearable device integration and local data processing.
Compare Cuspart: Blood Sugar against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for Cuspart: Blood Sugar
Strengths to defend, gaps to attack
Core Strengths
- Local-only data architecture eliminates cloud-based security risks
- One-time purchase model removes recurring subscription friction
Critical Frictions
- Zero Android rating count indicates low platform penetration
- Manual logging requirement increases user friction vs CGM-integrated rivals
Growth Levers
- Develop Apple Health and Google Fit integration to reduce manual entry
- Target privacy-conscious users migrating from cloud-heavy competitors
Market Threats
- Shotsy's predictive medication modeling creates higher clinical value
- Gluroo's wearable-first data visualization drains the high-tech user segment
What are the next best moves?
Ship Apple Health and Google Fit integration because manual logging is the primary friction point → increase daily retention
Competitors like Shotsy leverage ecosystem data loops to provide superior value.
Trade-off: Deprioritize the UI redesign of the reporting module — data utility outweighs aesthetic updates.
Audit Android onboarding flow because the platform has zero ratings since launch → improve conversion
The Android version launched in April 2026 but has failed to generate any user feedback.
Trade-off: Pause the development of new chart visualization types — current charts are sufficient for core utility.
A counter-intuitive read
The privacy-first local storage is not just a feature but a B2B distribution barrier, as it allows the app to bypass the complex HIPAA compliance hurdles that prevent cloud-based trackers from entering certain clinical partnerships.
Feature Gaps vs Competitors
- Automated CGM integration (available in GotCGM but missing here)
- Predictive medication level estimation (available in Shotsy but missing here)
- Collaborative caregiver monitoring (available in Staging Diabetes Logger but missing here)
Key Takeaways
Cuspart secures a privacy-focused niche through its local-first architecture, but the lack of automated CGM integration limits its long-term retention against hardware-connected rivals, so the PM must prioritize ecosystem data syncing to remain competitive.
Where Is It Heading?
Mixed Signals
The medical tracking market is consolidating around apps that offer automated wearable integration, leaving manual-entry tools like Cuspart increasingly exposed. The PM must transition from a manual-logging utility to an integrated health hub to prevent user migration to hardware-connected competitors.
The recent Android launch expands the addressable market, allowing the app to capture users outside the iOS-only segment.
The total lack of Android ratings post-launch suggests low discovery or high friction in the initial user funnel.